Genome Signature HRD Test
Introduction to Genome Signature HRD
The Genome Signature HRD test is an advanced diagnostic tool designed to identify homologous recombination deficiency (HRD) in tumor tissues. This genetic test plays a critical role in the management of cancer, particularly in guiding treatment decisions for patients with specific cancer types. Understanding your genetic predisposition can lead to more personalized and effective treatment strategies.
What the Test Measures
The Genome Signature HRD test measures the presence of genomic alterations that indicate HRD, which is associated with various cancers, including breast and ovarian cancers. By analyzing tumor tissue and peripheral blood samples, this test provides insights into the tumor’s genetic makeup, allowing healthcare providers to tailor treatment to the individual’s needs.
Who Should Consider This Test?
This test is particularly beneficial for patients who:
- Have a family history of breast or ovarian cancer.
- Are diagnosed with cancer and want to understand their genetic risk.
- Are considering treatment options that may be influenced by HRD status.
- Experience symptoms associated with hereditary cancer syndromes.
Benefits of Taking the Test
- Provides critical information for personalized cancer treatment.
- Helps identify patients who may benefit from targeted therapies.
- Can inform family members about potential genetic risks.
- Supports informed decision-making regarding treatment options.
Understanding Your Results
Results from the Genome Signature HRD test will indicate whether HRD is present. A positive result may suggest that specific targeted therapies could be effective. It is essential to discuss your results with your healthcare provider to understand the implications and next steps in your treatment plan.
Test Pricing
| Price Type | Amount (KSh) |
|---|---|
| Discount Price | 540,000 |
| Regular Price | 720,000 |
Booking Your Test
We offer the Genome Signature HRD test at our branches across Kenya, ensuring accessibility for all patients. To book your test or for more information, call or WhatsApp us at +254746849631.
Additional Information
Turnaround time for results is approximately 3-4 weeks. The test requires a sample of tumor tissue and peripheral blood, collected using paraffin embedded tissue blocks, EDTA Vacutainer (2ml), and a Streck tube. Please note that a doctor’s prescription is required for this test, except in cases of surgery, pregnancy, or travel abroad.
